Development of a new dyspepsia impact scale: The Nepean Dyspepsia Index

Alimentary Pharmacology and Therapeutics

Volumn 13, Issue 2, 1999, Pages 225-235

  Talley, N J ^a   Haque, M ^b   Wyeth, J W ^b   Stace, N H ^b   Tytgat, G N J ^c   Stanghellini, V ^d   Holtmann, G ^e   Verlinden, M ^f   Jones, M ^g  

^a UNIVERSITY OF SYDNEY   (Australia)

^b WELLINGTON HOSPITAL   (New Zealand)

^c Dept of Gastroenterology Hepatology ^*  (Netherlands)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e UNIVERSITY OF DUISBURG ESSEN   (Germany)

^f ABBOTT LABORATORIES   (United States)

^g INSTAT Australia   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DRINKING; DYSPEPSIA; EATING; FACTORIAL ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; SLEEP; SYMPTOM; WELLBEING; WORK CAPACITY;

ADULT; AGED; DYSPEPSIA; FEMALE; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE;

EID: 0032992354     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1999.00445.x     Document Type: Article

References (29)

1. Glise H, Hallerback B, Wiklund I. Quality of life: a reflection of symptoms and concerns. Scand J Gastroenterol 1996; 31(Suppl. 221): 14-17.
2. Guyatt GH. Measuring quality of life: a review of means of measurement in clinical trials of new medicines. Pharm Med 1987; 2: 49-60.
3. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med 1993; 118: 622-9.
4. Guyatt GH, Jaaeschke R. Measurement in clinical trials; choosing the appropriate approach. In: Spilker B, ed. Assessment in Clinical Trials. New York, Raven Press, 1990: 37.
5. Guyatt G, Deyo RA, Charlson M, Levine MN, Mitchell A. Responsiveness and validity in health status measurement: a clarification. J Clin Epidemiol 1989; 42: 403-8.
6. Talley NJ, Weaver AL, Zinsmeister AR. Impact of functional dyspepsia on quality of life. Dig Dis Sci 1995; 40: 584-9.
7. Dimenäs E, Glise H, Hallerback B, Hernqvist H, Svedlund J. Wiklund I. Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. Scand J Gastroenterol 1995; 30: 1046-52.
8. Wiklund I, Glise H, Jerndal P, Carlsson J, Talley NJ. Does endoscopy have a positive impact on quality of life in dyspepsia? Gastrointest Endosc 1998; 47: 449-54.
9. Stewart AL, Greenfield S, Hays RD, et al. Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study. J Am Med Assoc 1989; 262: 907-13.
10. Veldhuyzen van Zanten SJO, Cleary C, Talley NJ, et al. Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials. Am J Gastroenterol 1996; 91: 660-73.
11. Hahn BA, Kirchdoerfer LJ, Fullertson Mayer E. Patient-perceived severity of irritable bowel syndrome in relation to symptoms, health resource utilization and quality of life. Aliment Pharmacol Ther 1997: 11: 533-59.
12. Whitehead WE, Burnett CK, Cook EW, Taub E. Impact of irritable bowel syndrome on quality of life. Dig Dis Sci 1996; 41: 2248-53.
13. Talley NJ. Lambert JR, Howell S, Xia HH-X, Lin SK. Agreus L. An evaluation of whole blood testing for Helicobacter pylori in the general practice. Aliment Pharmacol Ther 1998; 12: 641-5.
14. Talley NJ, Boyce P, Owen BK, Newman P, Paterson K. Initial validation of a bowel symptom questionnaire and measurement of chronic gastrointestinal symptoms in Australia. Aust NZ J Med 1995; 40: 1345-50.
15. Talley NJ, Phillips SF, Melton LJ III, Wiltgen C, Zinsmeister AR. A patient questionnaire to identify bowel disease. Ann Intern Med 1989; 111: 671-4.
16. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care 1992; 30: 473-83.
17. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951; 16: 297-334.
18. Jones RH. Clinical economics review: gastrointestinal disease in primary care. Aliment Pharmacol Ther 1996; 10: 233-9.
19. de Bruin AF. Diederiks JP, de Witte LP, Stevens FC, Philipsen H. Assessing the responsiveness of a functional status measure: the Sickness Impact Profile versus the SIP68. J Clin Epidemiol 1997: 50: 529-40.
20. el-Omar EM, Banerjee S, Wirz A, McColl KE. The Glasgow dyspepsia severity score - a tool for the global measurement of dyspepsia. Eur J Gastroenterol Hepatol 1996; 8: 967-71.
21. Jonsson BH, Theorell T, Gotthard R. Symptoms and personality in patients with chronic functional dyspepsia. J Psychosom Res 1995; 39: 93-102.
22. Haug TT, Wilhelmsen I, Berstad A, Ursin H. Life events and stress in patients with functional dyspepsia compared with patients with duodenal ulcer and healthy controls. Scand J Gastroenterol 1995; 30: 524-30.
23. Lindell GH, Celebioglu F, Graffner HO. Non-ulcer dyspepsia in the long-term perspective. Eur J Gastroenterol Hepatol 1995; 7: 829-33.
24. Kurata JH, Nogawa AN, Chen YK, Parker CE. Dyspepsia in primary care: perceived causes, reasons for improvement, and satisfaction with care. J Fam Pract 1997; 44: 281-8.
25. Cuperus P. Keeling PW, Gibney MJ. Eating patterns in functional dyspepsia: a case control study. Eur J Clin Nutr 1996: 50: 520-3.
26. Lond E, Varmann P, Elshtein N, et al. Dyspepsia in rural residents of Estonia. Life-style factors, psychoemotional disorders, and familial history of gastrointestinal diseases. Scand J Gastroenterol 1995; 30: 826-8.
27. Talley NJ, Piper DW. Comparison of the clinical features and illness behaviour of patients presenting with dyspepsia of unknown cause (essential dyspepsia) and organic disease. Aust NZ J Med 1986; 16: 352-9.
28. Mertz H, Fass R, Kodner A, Yan-Go F, Fullerton S, Mayer FA. Effect of amitriptyline on symptoms, sleep and visceral perception in patients with functional dyspepsia. Am J Gastroenterol 1998; 93: 160-5.
29. David D, Mertz H, Fefer L, et al. Sleep and duodenal motor activity in patients with severe non-ulcer dyspepsia. Gut 1994; 35: 916-25.